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Maike Hildenbrand1, Verena Rhiemeier1, Bettina Hartenstein1, Bernd Lahrmann2,3, Niels Grabe2,3,
Peter Angel1 and Jochen Hess1
Recently, we identified an AP-1-dependent target gene in 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated
mouse back skin, which encodes a retroviral-like aspartic proteinase (Taps/Asprv1). Taps expression was
detected almost exclusively in stratified epithelia of mouse embryos and adult tissues, and enhanced protein
levels were present in several non-neoplastic human skin disorders, implicating a crucial role for differentiation
and homeostasis of multilayered epithelia. Here, we generated a mouse model in which Taps transgene
expression is under the control of the human ubiquitin C promoter (UBC-Taps). Although no obvious
phenotype was observed in normal skin development and homeostasis, these mice showed a significant delay
in cutaneous wound closure compared with control animals. Shortly after re-epithelialization, we found an
increase in keratinocytes in the stratum granulosum, which express Filaggrin, a late differentiation marker.
A hypergranulosum-like phenotype with increased numbers of Filaggrin-positive keratinocytes was also
observed in UBC-Taps mice after administration of TPA. In summary, these data show that aberrant Taps
expression causes impaired skin regeneration and skin remodeling after cutaneous injury and chemically
induced hyperplasia.
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INTRODUCTION
The skin is the outermost layer of the body and is a protective
barrier for internal tissues against environmental stress,
chemical damage, and bacterial infection (Presland and
Jurevic, 2002). It is composed of two layers: the epidermis
and the dermis, separated by the basement membrane. The
epidermis forms a stratified epithelium with several layers of
keratinocytes at different stages of differentiation. The basal
layer rests on the basement membrane and gives rise to
differentiated cells of the spinous layer, the granular layer,
and the stratum corneum. Only nondifferentiated cells in the
innermost basal layer are capable of undergoing cell division.
Induced by an as yet unknown signal, keratinocytes leave the
basal layer and start to migrate to the body surface, but along
the way they undergo morphological and biochemical
changes before they become terminally differentiated (Michel
et al., 1988; Fuchs and Raghavan, 2002; Kalinin et al., 2002).
The epidermis in adults is constantly in a process of self-
renewal, and the switch between keratinocyte proliferation
and differentiation has to be tightly controlled, because
deregulation can lead to severe skin diseases such as
hyperkeratosis, hyperplasia, or cancer (Koster and Roop,
2004; Fuchs, 2007).
Keratins are involved in the cytoskeletal assembly of
keratinocytes and belong to the class of intermediate
filaments. Expression of specific sets of keratins is commonly
used as molecular markers to define the differentiation status
of a given epithelial cell. Basal keratinocytes mainly express
Keratin 5 and 14, which constitute up to 25% of the total
amount of basal cell proteins (Fuchs, 1990). As keratinocytes
become localized to the suprabasal layers, the cells undergo
a program of terminal differentiation and switch to the
expression of Keratin 1 and 10 and stop producing Keratin 5
and 14 (Bowden et al., 1987). In the granular layer,
keratinocytes synthesize a histidine-rich, basic protein named
filaggrin, and form larger macrofibrillar bundles of tonofila-
ments (Dale et al., 1985). Eventually, keratinocytes reach the
cornified layer, the final stage of differentiation (Kalinin et al.,
2002), and express loricrin as the main component, before
they terminate their metabolism (Mehrel et al., 1990).
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In an effort to identify previously unknown tumor-
associated genes in epidermal keratinocytes, we accom-
plished a global gene expression approach and found
enhanced expression of several known as well as unknown
genes in back skin samples of mice treated with the phorbol
ester TPA (12-O-tetradecanoylphorbol-13-acetate), a potent
inducer of the transcription factor activator protein-1 (AP-1)
(Breitenbach et al., 2001; Rhiemeier et al., 2006). AP-1 is a
well-known regulator of genetic processes implicated in
epithelial differentiation, regeneration, homeostasis, and
cancer (Zenz and Wagner, 2006; Durchdewald et al.,
2009). One of the unknown genes encodes for a protein
with significant homology to retroviral-type aspartic protei-
nases, including a conserved DSG motif of the active site.
Therefore, we named this gene Taps for TPA-inducible
aspartic proteinase-like gene in skin (Rhiemeier et al., 2006).
We along with others found that Taps expression during
embryogenesis and in adult tissues was almost exclusively
detectable in multilayered epithelia (Matsui et al., 2006;
Rhiemeier et al., 2006). Moreover, various non-neoplastic
human skin lesions, including psoriasis, lichen ruber,
eczema, and actinic keratosis, exhibit high TAPS protein
levels suggesting that Taps is critically involved in the
development, differentiation, and homeostasis of stratified
epithelia (Bernard et al., 2005; Rhiemeier et al., 2006).
However, complete ablation of Taps expression in knockout
mice did not yield any obvious phenotype during skin
development or differentiation, questioning an essential role
for Taps in these processes (Matsui et al., 2006).
In this study, we describe a complementary approach by
generating a transgenic mouse model with ectopic Taps
expression in the skin and define the consequence of
transgene expression on cutaneous wound healing and
TPA-induced hyperplasia.
RESULTS
Generation and phenotype of UBC-Taps-transgenic mice
To establish a conditional mouse model with aberrant Taps
expression, we cloned a construct with a lacZ gene sharing a
translation stop codon, which was flanked by LoxP sites in
front of the coding sequence for the mouse Taps protein fused
to an Myc/His tag (Figure 1a). Both the lacZ gene cassette and
the Taps-Myc/His coding sequence were under the control of
the human ubiquitin C promoter (UBC). The transgene
construct was injected in fertilized oocytes to generate
UBC-lacZ-Taps founder animals. Offspring of two indepen-
dent founders were crossed twice with CMV-Cre transgenic
mice to ensure germ-line deletion of the lacZ gene cassette
and to establish UBC-Taps lineages with transgenic Taps
transcription in all tissues analyzed (see Supplementary Figure
S1a online). Offspring were born in the expected Mendelian
ratio and no obvious difference was detectable between the
two UBC-Taps lineages (data not shown). For further analysis,
we used only one lineage and animals of the corresponding
UBC-lacZ-Taps lineage that showed no Taps transgene
expression as proper controls (Supplementary Figure S1b).
At first, we analyzed back skin from newborn mice to
determine the effect of ectopic Taps expression on skin
development and homeostasis under non-challenging condi-
tions. As expected, significant expression of endogenous Taps
protein was observed in epidermal keratinocytes of the
suprabasal layer on skin sections of control animals. The
staining intensity was broader in the epidermis of UBC-Taps
newborns and ectopic Taps expression was also found in some
stromal cells of the dermis, confirming efficient transgene
expression (Figure 1b). Despite the difference in the overall
Taps protein level, we did not observe any difference in
histology or expression of the early differentiation marker
Keratin 10 and the late differentiation marker Loricrin (Figure
1b). Similarly, we found no obvious alterations in histology or
marker gene expression between 12-week-old control and
UBC-Taps mice (Supplementary Figure S2), suggesting that
aberrant Taps expression has no impact on the normal
development and homeostasis of unchallenged skin.
Taps expression is inducible during cutaneous wound healing
Previous observations that Taps expression in adult mice was
strongly induced under stress conditions, such as phorbol
ester treatment, and that its protein levels were strongly
enhanced in human skin under pathological conditions
(Bernard et al., 2005; Rhiemeier et al., 2006) motivated us
to investigate the process of cutaneous wound healing in our
transgenic animals. First, we performed 4mm full-thickness
excisional wounds at the back skin of 10- to 12-week-old
control and UBC-Taps females and prepared tissue samples
1, 3, 5, 7, and 10 days after wounding.
The transgenic transcript could be detected throughout the
whole wound kinetic (data not shown). Indirect immuno-
fluorescent analysis with an anti-Taps antibody on tissue
sections of control wounds revealed strong stainings for
endogenous Taps protein in keratinocytes at the wound edge
(Figure 2a; days 3 and 5) and shortly after re-epithelialization
(Figure 2a; days 7 and 10). However, signals for Taps protein
levels were more expanded on tissue sections of UBC-Taps
mice compared with controls, which were visible on wounds
of day 3 and significant on wounds of day 5 (Figure 2a and b).
Impaired cutaneous wound closure in UBC-Taps mice
To define the consequences of aberrant Taps expression on
cutaneous wound healing, we performed macroscopic
examinations of UBC-Taps mice and control animals, which
revealed no major difference for all individuals tested
(Supplementary Figure S3). However, histological analysis
of the wound section by indirect immunofluorescence
staining for the activation marker Keratin 6 unraveled a
significant delay in epithelial wound closure in UBC-Taps
mice on days 3 and 5 after wounding compared with controls
(Figure 3). Similar data were obtained by Trichrome staining
on wound sections that further confirm a significant impact of
Taps protein expression on the kinetic of wound closure (data
not shown).
Impact of Taps expression on keratinocyte proliferation and
differentiation
Induction of keratinocyte proliferation at the wound edge is
one of the initial events during cutaneous wound healing that
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critically contributes to the efficiency of wound closure.
Thus, we accomplished immunohistochemistry staining for
the proliferation marker proliferating cell nuclear antigen
(Pcna) on wound sections from control and UBC-Taps
animals. As expected, we could detect high numbers of
Pcna-positive keratinocytes at the wound edge of control
animals (Figure 4a). However, no obvious difference was
present between UBC-Taps and control wounds, showing
that aberrant Taps expression had no significant impact on
the proliferation status of keratinocytes after wounding
(Figure 4b).
Next, we asked whether ectopic Taps expression
altered the differentiation capacity of keratinocytes and
thereby influenced the kinetic of wound closure in transgenic
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Figure 1. Generation and phenotype of UBC-Taps transgenic mice. (a) Schematic representation of the transgene construct sharing a lacZ gene with a
translation stop codon, which was flanked by loxP sites (black triangles) and the coding sequence for the Taps-Myc/His fusion protein (upper panel: UBC-lacZ-
Taps transgenic mice). Both genes were under the control of the human ubiquitin C promoter (UBC). Backcrossing with CMV-Cre mice ensured germ-line
deletion of the lacZ gene cassette (lower panel: UBC-Taps transgenic mice). (b) Sections of back skin from newborn mice were stained with hematoxylin/eosin
(H&E) (upper panel) or indirect immunofluorescence using antibodies for the early differentiation marker Keratin 10 (red signal), the late differentiation marker
Loricrin (red signal), or Taps (red signal). Nuclei were counterstained with Hoechst dye (blue signal in each panel). White arrows indicate Taps staining in
stromal cells of the dermis. The left row consists of representative pictures from the back skin of control mice, and the middle and right rows consist of
representative pictures from the back skin of UBC-Taps mice. Five mice were analyzed per genotype. Bar¼ 50 mm.
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mice. Tissue sections of wounds from control and
UBC-Taps mice were stained by indirect immunofluores-
cence with different early (e.g., Keratin 10) and late
differentiation markers (e.g., Loricrin, Filaggrin). The number
of positive keratinocyte layers was quantified in relation to
the total amount of cell layers of the epidermis at the
wound edges or shortly after re-epithelialization (Figure 5,
data not shown). Although no difference was measured for
the thickness of the epidermis and of Keratin 10- or
Loricrin-positive keratinocytes (Supplementary Figure S4a
and b), we found an obvious increase in Filaggrin staining on
UBC-Taps wounds compared with controls (Figure 5).
However, this alteration was established with time
and was highly significant only on day 10 after wounding.
Therefore, it was unlikely that this difference was
directly correlated with the observed phenotype of delayed
wound closure at earlier time points of cutaneous wound
healing.
Taps transgenic mice develop a hypergranulosum-like
phenotype after TPA treatment
Our data from the wound healing experiments suggest that
aberrant Taps expression caused, at least during the late re-
epithelialization phase, alterations in features of terminally
differentiated keratinocytes. Therefore, we performed re-
peated TPA treatment (three times every 48 hours) on the
back skin of control and UBC-Taps mice, which resulted in a
hyperplastic epidermis because of accelerated keratinocyte
proliferation and differentiation. After 48 hours of the last
treatment, we prepared back skin of both genotypes and
accomplished histological analysis by hematoxylin/eosin
staining. Although repeated TPA administration had no major
impact on keratinocyte proliferation and epidermal thickness,
we detected a hypergranulosum-like phenotype on tissue
sections from UBC-Taps mice with increased amounts of
keratinocytes with granular inclusions compared with con-
trols (Figure 6 and Supplementary Figure S5). Again, indirect
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Figure 2. Taps protein expression during cutaneous wound healing. (a) Wounded back skin of control (left row) and UBC-Taps mice (right row) was prepared
after the indicated time points and stained by indirect immunofluorescence for Taps protein expression (red signal). The nuclei were counterstained with
Hoechst dye (blue signal). Only one side of the excisional wound is shown for day 1–5 after wounding. White dashed lines on days 3 and 5 after wounding
indicate the measured area for quantification of Figure 2b. Three to four wounds were analyzed per genotype and time point. Bar¼ 100 mm. (b) Quantification of
immunofluorescences on tissue sections of wounded back skin from control and UBC-Taps mice 3 and 5 days after wounding. The table shows the mean
intensity and the mean area in pixels with their corresponding SEM and P-values. Three wounds were analyzed per genotype and time point.
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immunofluorescence analysis revealed that a stronger stain-
ing for Taps protein in UBC-Taps mice correlated with
increased numbers of Filaggrin-positive keratinocytes in
suprabasal layers, whereas no difference was detected for
Keratin 10 and Loricrin (Figure 6).
We also established a transgenic mouse model with a
keratinocyte-specific Taps transgene expression using the
bovine Keratin 5 promoter (bK5-Taps). In line with our
experiments with the UBC-Taps transgenic mice, a difference
in keratinocyte proliferation was not found in bK5-Taps
transgenic mice compared with controls, although they also
develop a hypergranulosum-like phenotype with increased
numbers of Filaggrin-positive keratinocytes after TPA treat-
ment (Supplementary Figure S6).
DISCUSSION
In this study, we describe the generation and analysis of a
transgenic mouse model with increased expression of the
retroviral-like aspartic proteinase Taps. Previously, Taps
(SASPase/Asprv1) was identified as a putative aspartic
proteinase that was specifically expressed in differentiating
keratinocytes of multilayered epithelia in various mouse and
human tissues (Bernard et al., 2005; Rhiemeier et al., 2006).
Despite an increase in the overall Taps protein levels in the
skin of transgenic mice, no obvious alteration in epidermal
development, morphology, or differentiation was observed.
These findings, together with the published data on Taps-
deficient mice (Matsui et al., 2006), support the notion that its
expression has no major impact on keratinocyte physiology
under normal conditions. However, elevated TAPS protein
levels were found in several human skin disorders, including
psoriasis, lichen ruber, eczema, and actinic keratosis, and in
mouse back skin on administration of the phorbol ester TPA,
supporting the assumption that Taps function is implicated in
the epidermal regeneration and reestablishment of skin
homeostasis under pathological conditions (Bernard et al.,
2005; Rhiemeier et al., 2006). Consequently, we studied the
regulation and function of Taps in the process of cutaneous
wound healing, in which keratinocytes appropriately have to
adjust genetic programs controlling cell proliferation, migra-
tion, or differentiation. The wound healing experiments
reveal a specific induction of endogenous Taps protein
expression in keratinocytes at the wound edge and shortly
after re-epithelialization of control animals. In UBC-Taps
transgenic mice, we measured a significant delay in wound
closure by keratinocytes, which was not due to altered
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Figure 3. Impaired cutaneous wound closure in UBC-Taps mice. (a) Back skin of control (upper panel) and UBC-Taps mice (lower panel) was prepared
at the indicated time points after wounding and stained by indirect immunofluorescence for the activation marker Keratin 6 (red signal). Nuclei were
counterstained with Hoechst dye (blue signal). The white arrows indicate keratinocytes of the leading edge. Bar¼ 100 mm. (b) To quantify the difference in
wound closure according to Keratin 6-positive keratinocytes, we measured and analyzed the distance between keratinocyte migration fronts of wounds from
control (black circles) and UBC-Taps mice (white circles) with the UTHSCSA ImageTool. Four to six wounds were analyzed per genotype, and time point and
bars represent the mean±SEM. *Po0.05.
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keratinocyte proliferation or aberrant differentiation. One
possible explanation for the delay could be an impact of Taps
overexpression on keratinoctye migration. Although ectopic
Taps expression in an established mouse keratinocyte cell
line or transgene expression in primary keratinocytes did not
interfere with cell migration in an in vitro scratch assay
(Supplementary Figure S4c and VR and JH, unpublished
data), we cannot exclude the possibility that the secreted
protease modulates components of the extracellular matrix
and thereby inhibits cell–matrix adhesion and keratinocyte
migration in vivo. The delay in the wound kinetic could also
originate from an impact of aberrant Taps expression on the
production and processing of cytokines or chemokines that
affect the recruitment of immune cells. However, quantifica-
tion of neutrophils and mast cells on tissue sections revealed
no obvious difference in their recruitment, persistence, or
resolution between UBC-Taps transgenic and control mice,
whereas reduced numbers of F4/80-positive macrophages
were found on day 3 in some but not all UBC-Taps transgenic
mice (data not shown). These data suggest that alterations in
the activation and recruitment of immune cells are not the
major cause for the observed phenotype. Interestingly,
quantitative RT-PCR analysis revealed reduced endogenous
Taps transcript levels in skin samples of UBC-Taps compared
to control mice, supporting the hypothesis that Taps
expression is tightly controlled by a negative feedback
mechanism (Supplementary Figure S7a and b). Although the
molecular nature of this regulation remains elusive, these
data suggest that an aberrant spatial and temporal Taps
expression rather than simple Taps overexpression might
critically contribute to the observed phenotype in wound
healing in Taps transgenic mice. This assumption is further
supported through quantification of Taps immunofluores-
cences on tissue sections of wounded back skin from control
and UBC-Taps mice. The quantification revealed a higher
mean intensity of UBC-Taps wounds on days 3 and 5 after
wounding, which is not significant. However, quantification
of the mean area of keratinocytes in which Taps protein was
expressed revealed an obvious difference on day 3 after
wounding and a highly significant difference on day 5 after
wounding.
In addition to the delay in wound closure, UBC-Taps mice
showed an obvious difference in the relative number of
Filaggrin-positive keratinocytes compared with controls,
which was highly significant on day 10 after wounding. A
similar phenotype was also observed in UBC-Taps transgenic
mice after the induction of epidermal hyperplasia on TPA
treatment accompanied by an accumulation of keratinocytes
in the stratum granulosum.
Originally, we have identified Taps as a TPA-induced gene
in mouse back skin, whose expression critically depends on
the function of Fos, a member of the AP-1 transcription factor
family (Rhiemeier et al., 2006). It is well established that AP-1
is a key regulator of keratinocyte differentiation, proliferation,
and migration, and detailed analyses of genetically modified
mouse models and cell lines derived thereof revealed an
important role for distinct AP-1 family members in physio-
logical as well as pathophysiological conditions of the skin
(Angel et al., 2001; Zenz and Wagner, 2006). Specifically,
ablation of the Jun family members, Jun and JunB, in
keratinocytes of adult mice resulted in severe skin defects
with regard to cutaneous wound healing and skin home-
ostasis (Florin et al., 2006; Zenz et al., 2005). Interestingly,
we found that, in TPA-stimulated keratinocytes, JunB, but not
Jun, is part of an AP-1 complex, which binds to a conserved
TPA-responsive element on the Taps promoter. In addition,
ectopic JunB expression induces transcription of a luciferase
reporter gene under the control of the Taps promoter (data
not shown). Thus, it will be a major challenge in the future to
address the question whether altered Taps expression is, at
least in part, implicated in skin phenotypes that have been
observed in mouse models with JunB ablation in keratino-
cytes.
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Figure 4. Proliferation status of UBC-Taps and control mice during
re-epithelialization. (a) Keratinocyte proliferation on paraffin sections of back
skin wounds from control (upper panel) and UBC-Taps mice (lower panel) at
days 3 and 5 after wounding were analyzed by immunohistochemistry with
an antibody against the proliferation marker proliferating cell nuclear antigen
(Pcna) (red nuclei) and counterstained with hematoxylin (blue nuclei).
Bar¼100 mm. (b) The number of Pcna-positive keratinocytes of control (black
bars) and UBC-Taps wounds (white bars) was quantified in relation to the
total amount of keratinocytes in an area of 217.4 217.4 mm (1,000
1,000 pixels) on the indicated days after wounding and analyzed with the
UTHSCSA ImageTool. Four wounds were analyzed per genotype and time
point and bars represent the mean±SEM.
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Filaggrin is a crucial component of the cornified envelope
in the outer layer of the epidermis and aggregates the
keratin filaments into tight bundles, promoting the collapse
of the cell into a flattened shape, which is characteristic of
corneocytes in the cornified layer (Palmer et al., 2006).
The protein is synthesized initially as profilaggrin, an
approximately 500 kDa highly phosphorylated, histidine-rich
polypeptide, which consists of an N-terminal S100
calcium-binding domain and a downstream B domain,
whereas the central region of the protein comprises a tandem
organization of repeat units of the filaggrin polypeptide
(McGrath and Uitto, 2008). During cornification, profilaggrin
is dephosphorylated and proteolytically cleaved to
release individual filaggrin molecules (Resing et al., 1985,
1993). Hitherto, numerous proteases, such as CNDP
dipeptidase 2 (PEP1), calpain, furin, and the transmembrane
serine protease matriptase, have been shown to mediate
proteolytic processing of profilaggrin (Candi et al., 2005),
and it will be interesting to investigate whether Taps
expression under pathological conditions has an impact on
this process.
MATERIALS AND METHODS
Mice
The cDNA encoding the mouse Taps-Myc/His fusion protein
(Rhiemeier et al., 2006) was cloned in a plasmid with the UBC
promoter (Schorpp et al., 1996) and a lacZ reporter gene flanked by
loxP sequences (UBC-lacZ-Taps). On deletion of the lacZ reporter
gene by Cre recombinase, efficient Taps expression was observed in
transiently transfected cells (data not shown). The cDNA encoding
the mouse Taps-Myc/His fusion protein was also cloned in a plasmid
with the bK5-Taps (Ramirez et al., 2004). The Transgene Facility of
the DKFZ Heidelberg used linearized UBC-lacZ-Taps and bK5-Taps
plasmids to generate transgenic founders in a C57BL/6 or NMRI
genetic background, respectively. UBC-lacZ-Taps transgenic foun-
ders were crossed with CMV-Cre mice for at least two generations to
allow germ-line recombination and to ensure ubiquitous expression
of the Taps transgene.
All mice were housed in a specific pathogen-free environment
and under light-, temperature-, and humidity-controlled conditions.
Food and water were available ad libitum. The procedures
for performing animal experiments were in accordance with
the principles and guidelines of the ATBW (officials for animal
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Figure 5. Filaggrin protein expression in UBC-Taps and control mice during cutaneous wound healing. (a) Sections of back skin from control (upper panel)
and UBC-Taps (lower panel) mice were prepared at the indicated time points after wounding and were stained for the expression of the late differentiation
marker Filaggrin (red signal). Nuclei were counterstained with Hoechst dye (blue signal). Bar¼ 100mm. (b) Quantification of Filaggrin-positive cell layers of
wounds from control (black bars) and UBC-Taps mice (white bars) at the indicated time points after wounding was performed and set in relation to the
total amount of cell layers of the epidermis using the UTHSCSA ImageTool. Four to seven wounds were analyzed per genotype, and time point and bars
represent the mean±SEM. **Po0.005.
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welfare) and were approved by the Regierungspra¨sidium Karlsruhe,
Germany.
Wounding study
Control (UBC-lacZ-Taps) and UBC-Taps female mice aged 10–12
weeks were anesthetized with Ketavet and Rompun and two paired
4mm diameter, full-thickness excisional wounds were made using a
sterile biopsy punch (Stiefel, Wa¨chtersbach, Germany) through the
shaved and fumigated skin on the back of each mouse. At 1, 3, 5, 7,
and 10 days after wounding, mice were killed by cervical dislocation
and the wound tissue and surrounding wound margin skin were
harvested. Two wounds were divided into two parts: (i) one half for
embedding in paraffin and (ii) one half for embedding in OCT
Compound (Tissue Tek, Vogel, Giessen, Germany). The other two
wounds were frozen in liquid nitrogen and stored at 80 1C for RNA
preparation.
TPA treatment
Back skin of control and transgenic mice were shaved and, after
48 hours, treated three times every 48 hours with 100mM TPA or
solvent alone (acetone). After 48 hours of the last treatment, we
isolated and fixed the skin in 4% paraformaldehyde at 4 1C overnight
and embedded it in paraffin for histological analyses.
Immunofluorescence analyses and immunohistochemistry
Pretreatment of tissue sections and stainings were performed as
previously described (Hartenstein et al., 2006).
Sections were stained with the following primary antibody
solutions: rabbit anti-mouse Loricrin (1:400; Covance, Princeton,
NJ), rabbit anti-mouse Filaggrin (1:500; Abcam, Cambridge, UK),
rabbit anti-mouse Keratin 10 (1:250; Covance), rabbit anti-mouse
Keratin 6 (1:500; Covance), mouse anti-mouse Pcna (1:300; Santa
Cruz Biotechnology, Santa Cruz, CA), rabbit anti-mouse Taps (1:500;
Rhiemeier et al. (2006)).
Image acquisition was performed by fluorescence microscopy
using a Keyence BZ-8000K epifluorescence microscope (Keyence,
Neu-Isenburg, Germany).
Analyses were performed using the free UTHSCSA ImageTool
program (developed at the University of Texas Health Science
Center, San Antonio, Texas, and available from the Internet by
anonymous FTP from ftp://maxrad6.uthscsa.edu)
Quantification of immunofluorescence staining
Fluorescence images of wounds from control and UBC-Taps mice
3 and 5 days after wounding were used for quantification. All images
had a resolution of 4,080 3,072 pixels with 256 intensity levels for
each ‘‘RGB’’ component. Protein level measurements of the stored
images were performed with Matlab (MathWorks, Natick, MA) using
the image processing toolbox.
To avoid the measurement of protein levels from glands or hair
follicles, we manually segmented the areas of interest (keratinocytes of
the wound edge) using Photoshop (Adobe Systems, Mountain View,
CA). In the next step, images that contained only the red component
(Taps protein expression) were extracted from the RGB images. The
output of this step is an intensity image representing the pixel values of
the red component of the RGB image. Binary image masks were
generated to define regions of interest for analysis of the pixel intensities
and to calculate the area of pixels. On this basis, we measured the
intensity values of each pixel within the manually segmented area of the
red component image and calculated the mean intensity values.
Statistical procedures
Statistical analysis was carried out using a two-tailed Student’s
unpaired t-test, and according to conventional criteria, P-values of
0.05 were considered statistically significant.
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Figure 6. UBC-Taps mice develop a hypergranulosum-like phenotype after
12-O-tetradecanoylphorbol-13-acetate (TPA) treatment. Back skin of control
(left panel) and UBC-Taps mice (right panel) was treated three times with
TPA, and 48 hours after the last treatment, the skin was prepared and analyzed
by hematoxylin/eosin (H&E) staining and indirect immunofluorescent
stainings for Taps protein expression, the early differentiation marker Keratin
10, and the late differentiation markers Loricrin as well as Filaggrin (red
signal). The nuclei were counterstained with Hoechst dye (blue signal).
Four mice were analyzed per genotype. Bar¼100 mm.
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